Medindia LOGIN REGISTER
Medindia
Advertisement

Using Central Venous Catheters for Kidney Disease may Harm Patients

by Medindia Content Team on October 14, 2007 at 11:26 AM
Using Central Venous Catheters for Kidney Disease may Harm Patients

A new research has revealed that a technique known as central venous catheters used to provide permanent hemodialysis for patients with kidney disease may indeed harm them.

The technique, where a catheter is inserted through large vessels, has been commonly used worldwide in recent years.

Advertisement

The new study has found that this treatment may block the blood flow in the vessel, leading to superior vena cava syndrome (SVC syndrome), a highly serious complication caused by the obstruction of blood coming to the heart from the upper body.

The symptoms of SVC syndrome include shortness of breath, swelling of the upper limbs, neck and face, which occur as the catheter, generally inserted into a large blood vessel, blocks blood flow.
Advertisement

The study stresses the need for doctors to be able to identify SVC syndrome symptoms in order to prevent more serious complications.

"The increasing use of central vein catheters for long-term hemodialysis has contributed high rates of complications," said Hadim Akoglu, M.D., author of the study.

"It seems that SVC syndrome due to central vein catheters will become an important threat as the popularity of this treatment continues to grow," Akoglu added.

Akoglu has recommended that the harmful effects of SVC syndrome can be counteracted if catheters are only used for short periods of time.

Treatments for SVC syndrome are also being devised, including thrombolytic therapy, where blood clots are pharmacologically dissolved; percutaneous transluminal balloon angioplasty (PTA); intravascular stent placement; and surgical reconstruction, which re-opens blood flow access in the vessel.

This new study is published in the October issue of Hemodialysis International.

Source: ANI
SRM /B
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Can Sleep Brain Waves Defend Against Epileptic Activity?
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Using Central Venous Catheters for Kidney Disease may Harm Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests